DADA2 presenting as nonimmune hemolytic anemia with recurrent macrophage activation syndrome

Pediatr Blood Cancer. 2022 Jun;69(6):e29461. doi: 10.1002/pbc.29461. Epub 2021 Nov 22.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adenosine Deaminase
  • Agammaglobulinemia
  • Anemia, Hemolytic*
  • Humans
  • Intercellular Signaling Peptides and Proteins
  • Macrophage Activation Syndrome* / diagnosis
  • Macrophage Activation Syndrome* / etiology
  • Severe Combined Immunodeficiency

Substances

  • Intercellular Signaling Peptides and Proteins
  • Adenosine Deaminase

Supplementary concepts

  • Severe combined immunodeficiency due to adenosine deaminase deficiency